Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
3.590
-0.110 (-2.97%)
At close: Oct 15, 2026, 4:00 PM EDT
3.660
+0.070 (1.95%)
After-hours: Oct 15, 2026, 7:33 PM EDT
Unicycive Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
22
Market Cap
100.00M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 675.00K | -276.00K | -29.02% |
| Dec 31, 2022 | 951.00K | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Tonix Pharmaceuticals Holding | 29.10M |
| LENZ Therapeutics | 21.48M |
| Coya Therapeutics | 8.02M |
| Rani Therapeutics Holdings | 4.88M |
| Cibus | 4.35M |
| Milestone Pharmaceuticals | 2.34M |
| Humacyte | 2.12M |
| Inovio Pharmaceuticals | 65.34K |
UNCY News
- 14 hours ago - SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 2, 2026 in Unicycive Therapeutics, Inc. Lawsuit - UNCY - PRNewsWire
- 14 days ago - Kaplan Fox Reminds Unicycive Therapeutics, Inc. (UNCY) Investors to Seek a Leadership Role Before Deadline on November 2, 2026 - Newsfile Corp
- 14 days ago - Unicycive Therapeutics appoints Manning to its Board of Directors - TheFly
- 14 days ago - Unicycive Therapeutics Appoints Meredith Manning to Board of Directors - GlobeNewsWire
- 16 days ago - Kaplan Fox Notifies Investors of Unicycive Therapeutics, Inc. (UNCY) of the Lead Plaintiff Deadline on November 2, 2026 - Newsfile Corp
- 16 days ago - Unicycive Therapeutics price target lowered to $13 from $15 at H.C. Wainwright - TheFly
- 16 days ago - Unicycive Therapeutics announces resubmission of NDA for OLC - TheFly
- 16 days ago - Unicycive Therapeutics Announces Resubmission of New Drug Application for Oxylanthanum Carbonate - GlobeNewsWire